Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01), MarketWatch Earnings reports. The business had revenue of $2.73 million during the quarter. Sonoma Pharmaceuticals had a negative net margin of 50.75% […]
Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01), MarketWatch Earnings reports. Sonoma Pharmaceuticals had a negative return on equity of 71.86% and a negative net margin of 50.75%. The company had revenue of […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 41,500 shares, an increase of 15.9% from the September 30th total of 35,800 shares. Based on an average daily volume of 25,400 shares, […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Significant Decrease in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 37,400 shares, a decline of 29.6% from the July 15th total of 53,100 shares. Based on an average daily trading volume, of 506,200 […]